Skip to main content
. Author manuscript; available in PMC: 2012 Aug 19.
Published in final edited form as: Biochem Biophys Res Commun. 2011 Jul 22;412(1):55–60. doi: 10.1016/j.bbrc.2011.07.036

Fig. 2.

Fig. 2

(A) Western blotting of LC3-I/II conversion and COX-IV degradation in STS-treated HeLa cells, HeLa1.2 cells, and ρ° HeLa1.2 cells. (B) Effect of wortmannin and PEG-SOD on STS-induced LC3-I/II flux in HeLa1.2 cells. (C) Effect of Bafilomycin-A1 on rotenone- and STS-induced LC3-I/II conversion in HeLa1.2 cells. (D) TEM of STS-treated HeLa1.2 cells. (a) control; cells treated with STS for 6h (b) and 2h (c); (d) Enlargement of the rectangular selected area in c. Data presented are representative of three independent experiments. (E–H) Representative confocal images of HeLa1.2 cells transiently expressing GFP-LC3.